Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2009 1
2010 3
2011 2
2012 2
2014 1
2015 2
2017 1
2018 2
2019 7
2020 7
2021 11
2022 14
2023 8
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

58 results

Results by year

Filters applied: . Clear all
Page 1
PCSK9 inhibition with orally administered NNC0385-0434 in hypercholesterolaemia: a randomised, double-blind, placebo-controlled and active-controlled phase 2 trial.
Koren MJ, Descamps O, Hata Y, Hengeveld EM, Hovingh GK, Ikonomidis I, Radu Juul Jensen MD, Langbakke IH, Martens FMAC, Søndergaard AL, Witkowski A, Koenig W. Koren MJ, et al. Among authors: hata y. Lancet Diabetes Endocrinol. 2024 Mar;12(3):174-183. doi: 10.1016/S2213-8587(23)00325-X. Epub 2024 Feb 1. Lancet Diabetes Endocrinol. 2024. PMID: 38310920 Clinical Trial.
Erratum to 'SYNTAX Score and 1-Year Outcomes in the OPTIVUS-Complex PCI Study Multivessel Cohort' [American Journal of Cardiology (2023) 431-441].
Gohbara M, Hibi K, Morimoto T, Kirigaya H, Yamamoto K, Ono K, Shiomi H, Ohya M, Yamaji K, Watanabe H, Amano T, Morino Y, Takagi K, Honye J, Matsuo H, Abe M, Kadota K, Ando K, Nakao K, Sonoda S, Suwa S, Kawai K, Kozuma K, Nakagawa Y, Ikari Y, Nanasato M, Hanaoka K, Tanabe K, Hata Y, Akasaka T, Kimura T; OPTIVUS-Complex PCI investigators. Gohbara M, et al. Among authors: hata y. Am J Cardiol. 2024 Jan 15;211:382. doi: 10.1016/j.amjcard.2023.12.013. Epub 2023 Dec 16. Am J Cardiol. 2024. PMID: 38114058 No abstract available.
Clopidogrel vs Aspirin Monotherapy Beyond 1 Year After Percutaneous Coronary Intervention.
Watanabe H, Morimoto T, Natsuaki M, Yamamoto K, Obayashi Y, Nishikawa R, Ando K, Ono K, Kadota K, Suwa S, Morishima I, Yoshida R, Hata Y, Akao M, Yagi M, Suematsu N, Morino Y, Yokomatsu T, Takamisawa I, Noda T, Doi M, Okayama H, Nakamura Y, Hibi K, Sakamoto H, Noguchi T, Kimura T; STOPDAPT-2 Investigators. Watanabe H, et al. Among authors: hata y. J Am Coll Cardiol. 2024 Jan 2;83(1):17-31. doi: 10.1016/j.jacc.2023.10.013. Epub 2023 Oct 23. J Am Coll Cardiol. 2024. PMID: 37879491 Clinical Trial.
SYNTAX Score and 1-Year Outcomes in the OPTIVUS-Complex PCI Study Multivessel Cohort.
Gohbara M, Hibi K, Morimoto T, Kirigaya H, Yamamoto K, Ono K, Shiomi H, Ohya M, Yamaji K, Watanabe H, Amano T, Morino Y, Takagi K, Honye J, Matsuo H, Abe M, Kadota K, Ando K, Nakao K, Sonoda S, Suwa S, Kawai K, Kozuma K, Nakagawa Y, Ikari Y, Nanasato M, Hanaoka K, Tanabe K, Hata Y, Akasaka T, Kimura T; OPTIVUS-Complex PCI investigators. Gohbara M, et al. Among authors: hata y. Am J Cardiol. 2023 Oct 15;205:431-441. doi: 10.1016/j.amjcard.2023.08.043. Epub 2023 Sep 1. Am J Cardiol. 2023. PMID: 37660669
Clopidogrel Monotherapy After 1-Month DAPT in Patients With High Bleeding Risk or Complex PCI.
Yamamoto K, Watanabe H, Morimoto T, Obayashi Y, Natsuaki M, Domei T, Yamaji K, Suwa S, Isawa T, Watanabe H, Yoshida R, Sakamoto H, Akao M, Hata Y, Morishima I, Tokuyama H, Yagi M, Suzuki H, Wakabayashi K, Suematsu N, Inada T, Tamura T, Okayama H, Abe M, Kawai K, Nakao K, Ando K, Tanabe K, Ikari Y, Morino Y, Kadota K, Furukawa Y, Nakagawa Y, Kimura T; STOPDAPT-2 and STOPDAPT-2 ACS Investigators. Yamamoto K, et al. Among authors: hata y. JACC Asia. 2023 Jan 10;3(1):31-46. doi: 10.1016/j.jacasi.2022.09.011. eCollection 2023 Feb. JACC Asia. 2023. PMID: 36873770 Free PMC article.
Effects of luseogliflozin and voglibose on high-risk lipid profiles and inflammatory markers in diabetes patients with heart failure.
Ejiri K, Miyoshi T, Kihara H, Hata Y, Nagano T, Takaishi A, Toda H, Namba S, Nakamura Y, Akagi S, Sakuragi S, Minagawa T, Kawai Y, Nishii N, Fuke S, Yoshikawa M, Nakamura K, Ito H; MUSCAT-HF Study Investigators. Ejiri K, et al. Among authors: hata y. Sci Rep. 2022 Sep 14;12(1):15449. doi: 10.1038/s41598-022-19371-6. Sci Rep. 2022. PMID: 36104378 Free PMC article. Clinical Trial.
58 results